ADVENTA 7191 Share Price
RM1.00
52 Weeks Range : 0.46 - 5.18
3.2/10
(Expert Score)
Product is rated as #18 in category BM Health Care
PROS:
- Small Dividend Payout
- Positive Cash Company
- Low Gearing Ratio
- Very High Trading Value
CONS:
- Making Huge Loss
- Very Low Price-to-Tangible
klse: Adventa Bhd
Corporate Information
Board : Main
Shariah : Shariah Compliant
Sector : Ringgit Healthcare Gloves
Address: No. 21, Jalan Tandang, 51 / 205A, Seksyen 51, Petaling Jaya, 46050, Selangor
Contact: +603-77729321
Website: https://www.adventa.com.my/
Corporate Background
Adventa Berhad is an investment holding company. The Company, through its subsidiaries, manufactures and distributes sterile surgical and medical examination gloves as well as distributes medical and hospital related products. Adventa also generates and supplies energy and electricity using biomass technology.
Genaral Info: ADVENTA 7191
|
Result
Quarter Report History
| Date | Revenue,k | PBT,k | Net Profit,k |
|---|---|---|---|
| 26/02/21 | 12,706 | -9,984 | -9,285 |
| 25/11/20 | 14,466 | -5,227 | -5,227 |
| 26/08/20 | 46,373 | 1,579 | 1,691 |
| 21/05/20 | 13,674 | 908 | 1,008 |
| 27/02/20 | 11,642 | -6,057 | -6,457 |
| 26/11/19 | 9,522 | 29,432 | 30,211 |
| 29/08/19 | 9,249 | 364 | -384 |
| 30/05/19 | 8,486 | -435 | -1,229 |
| 28/02/19 | 7,773 | -27,056 | -27,427 |
| 26/12/18 | 9,589 | -608 | -569 |
| 28/09/18 | 13,420 | 1,373 | 757 |
| 20/06/18 | 15,360 | 1,316 | 702 |
Fundamental
Fundamental Analysis
| Last 4 Quarter Revenue (RM’000) | 87,219 |
|---|---|
| Last 4 Quarter Net Profit (RM’000) | -12,325 |
| Last 4 Quarter EPS (sen) | -7.69 |
| Last 4 Quarter PER | – |
| Last 4 Quarter Dividend (sen) | – |
| Last 4 Quarter Dividend Yield (%) | – |
| Net Tangible Assets (RM) | 0.36 |
| Goodwill (RM) | 3,620 |
| Cash (RM’000) | 12,310 |
| Debt (RM’000) | 2,690 |
| Total Debt (RM’000) | 27,720 |
| Net Assets (RM’000) | 64,500 |
| Current Ratio | 2.44 |
| Quick Ratio | 2.09 |
| Cash Ratio | 1.21 |
Technical
Technical Analysis
| MACD (26 vs 12) | -0.086 |
|---|---|
| Exponential Moving Average 5 | 0.799 |
| Exponential Moving Average 20 | 0.865 |
| Exponential Moving Average 90 | 1.319 |
| Relative Strength Index 14 | 0.28 |
| Stochastic %D 3 | 0.20 |
| Stochastic %K 14 | 0.35 |
4 reviews for ADVENTA 7191
Show all
Most Helpful
Highest Rating
Lowest Rating
BURSA MALAYSIA –
Revenue for 2Q 2020 was RM 46.37 million, a 337% increase compared to RM 1Q 2020 at RM 13.7m. The increase in revenue was contributed by the sales of PPE and other medical consumables linked to the Covid-19 pandemic and the effect of the movement controls.
REMUNERATION STUDY –
In Financial Year End 2019, the directors’ remuneration was 1.24 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 8 million and auditor’s remuneration of 135 thousands
BURSA MALAYSIA –
Revenue for 1Q 2020 was RM 13.67 million, an increase of 17% compared to RM 11.64 million in 4Q 2019. The increase in revenue was mainly contributed by the sales of PPE amid Covid-19 pandemic. Profit before tax and EBITDA reported improvement in current quarter were mainly due to better profit margin from the sales of PPE; Deferred development cost of home dialysis products was written off; Impairment of trade receivables.
Investing Malaysia –
Average investing volume for Adventa Bhd in the past three months in stock market was 245.1k lots
Investing Malaysia –
ADVENTA gets a score of 9.87 in our equity and assets quality test based on current share price of RM0.645
Investing Malaysia –
Adventa Bhd gets a score of 16.8 in our stability test after the balance sheet, money statement study
Investing Malaysia –
Stock code of 7191 in Bursa Malaysia did not propose any dividend for the past few years
Investing Malaysia –
ADVENTA is forecasted to made loss of 0.83 millions, with an adjusted market capitalization of 96.26 millions
REMUNERATION STUDY –
In Financial Year End 2018, the directors’ remuneration was 1.64 million. It was fair compared to average in listed companies, considering the employees’ remuneration of 8.4 million and auditor’s remuneration of 155 thousands